CLL | Tumor

CURE’s Chronic Lymphocytic Leukemia (CLL) page features the latest cancer news and updates on CLL Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in chronic lymphocytic leukemia.

Calquence Had Fewer Heart Complications Than Imbruvica in CLL Treatment

October 13th 2023, 10:00pm

Article

Fewer patients with chronic lymphocytic leukemia experienced cardiac toxicities with Calquence than those treated with Imbruvica, research showed.

If You Have To Have Cancer

October 13th 2023, 5:00pm

Article

Never underestimate your value to a person who has just been diagnosed. Isn’t that what these blogs are all about anyway?

Chronic Lymphocytic Leukemia Headlines from 2023

September 28th 2023, 8:58pm

Article

CURE looks back on some of the most important stories in the chronic lymphocytic leukemia space from 2023.

Frontline Imbruvica Plus Venclexta May Restore Immune Profiles in CLL

September 27th 2023, 9:00pm

Article

Patients with chronic lymphocytic leukemia treated with Imbruvica plus Venclexta demonstrated a healthy immune profile over time in addition to reduction in CLL disease burden.

MRD Testing Helped Patient with CLL Find ‘Peace of Mind’

August 31st 2023, 1:00pm

Video

A two-time breast cancer survivor who was diagnosed with chronic lymphocytic leukemia in 2020 discussed her belief in the power of minimal residual disease testing.

After More Than a Decade with CLL, MRD Results Left Patient ‘Over the Moon’

August 16th 2023, 1:00pm

Article

Geoff Grubbs, who was diagnosed with chronic lymphocytic leukemia in 2009, has undergone five lines of treatment and participated in two clinical trials.

I Was Told ‘You’re Not that Bad’ My Whole Life — Even During Cancer

July 28th 2023, 1:00pm

Article

After being told, "You're not that bad" my whole life, I continued to hear that after being diagnosed with leukemia — which some called "the best" cancer to have.

Breyzani Benefits Previously Treated SLL, CLL

July 12th 2023, 9:00pm

Article

CAR T-cell therapy positively benefitted patients with patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

Venclexta Plus Gazyva Induces Minimal Residual Disease, Improves Survival in CLL

July 9th 2023, 5:50pm

Article

Fit patients with chronic lymphocytic leukemia treated with Venclexta and Gazyva, regardless of the use of Imbruvica, experienced improvements in progression-free survival and were more likely to obtain undetectable minimal residual disease.

Triplet Therapy May Not Provide Additional Benefit in Older Patients With CLL

June 27th 2023, 1:00pm

Article

Patients 65 years and older treated with Venclexta, Imbruvica and Gazyva for CLL had similar rates of progression-free survival compared with those treated with Imbruvica and Gazyva.